Cellider Biotech was created with the goal of providing biomedical researchers with high quality cell-derived products to boost their research and move it one step closer to the clinical practice. Regenerative medicine has improved treatment options and patient quality of life for many diseases, and Cellider hopes to further improve treatment options for cartilage and bone related illness.
Cellider Biotech aims to become a leader in the adult stem cell field, providing key products and services for researchers. Their product range includes primary cultures, stem cells from different animals and sources, extracellular matrix, and biomaterials. Cellider Biotech invests part of its capital in Research and Development of new cell therapies with applications in veterinary and medical purposes.